TrialsgrambetaRCTs are beautiful

ORBITA-2

2023

A Placebo-Controlled Trial of PCI for Stable Angina

In 301 patients with stable angina on no antianginal medication, PCI improved the angina symptom score compared with a placebo procedure.

Result

Efficacy: Angina symptom scoreOR 2.21 · P < 0.001

Below 1 favours a placebo procedure, above 1 favours PCI.

Also reported: Corrects the negative ORBITA result.

Original publication
Subtopic
Revascularisation
Design
Sham-controlled, double-blind RCT
Relevance
Important: one of several pillars.
Cited in
ESC 2024 CCS
Source
Rajkumar CA, et al. N Engl J Med. 2023;389(25):2319-2330.doi 10.1056/NEJMoa2310610

Discussion & critique

Removing background antianginals (unlike ORBITA) unmasked a genuine symptom benefit of PCI. The endpoint is symptom-based rather than exercise time; the procedural placebo effect remains relevant.

Discussed in podcasts